Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001933797 | SCV002203595 | uncertain significance | Severe combined immunodeficiency due to LCK deficiency | 2021-09-01 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine with histidine at codon 222 of the LCK protein (p.Arg222His). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and histidine. This variant is present in population databases (rs749760246, ExAC 0.002%). This variant has not been reported in the literature in individuals affected with LCK-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV004041803 | SCV003743942 | uncertain significance | not specified | 2022-09-07 | criteria provided, single submitter | clinical testing | The c.665G>A (p.R222H) alteration is located in exon 8 (coding exon 7) of the LCK gene. This alteration results from a G to A substitution at nucleotide position 665, causing the arginine (R) at amino acid position 222 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |